Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Synthetic peptide from Demegen selectively targets cancerous prostate cells in vitro

April 12, 1999

AACR presentation for BN-80915, an improved camptothecin analogue

April 12, 1999

Preliminary clinical results for ABT-627 presented at this week's AACR meeting

April 12, 1999

Genset reaches milestone in prostate cancer collaboration with Synthelabo

April 12, 1999

Corvas reports design, synthesis and activity of selective peptidomimetic uPA inhibitors

April 9, 1999

Apoptosis-inducing peptide discovered at Morinaga Milk

April 9, 1999

Select Therapeutics submits pre-IND in Canada for anticancer compound

April 9, 1999

Aronex initiates phase I/II trial of Atragen in bladder cancer

April 9, 1999

EntreMed and NCI sign CRADA for 2-methoxyestradiol

April 8, 1999

Enzon files IND for PEG-camptothecin

April 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...